Carlsbad, CA, United States of America

Priscilla Lo


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Priscilla Lo: Innovator in Ophthalmic Compositions

Introduction

Priscilla Lo, based in Carlsbad, California, is an accomplished inventor recognized for her significant contributions to the field of ophthalmology. With a focus on enhancing eye care solutions, Priscilla holds a patent that underscores her innovative approach to preserving and disinfecting contact lens solutions.

Latest Patents

Priscilla Lo's sole patent is titled "Ophthalmic compositions and methods for preserving and using same." This invention details ophthalmic compositions, particularly aimed at the care of contact lenses. The patent discloses methods for preserving these compositions and outlines techniques for disinfecting contact lenses utilizing a specific blend of oxygen-containing ionene polymers and other antimicrobial agents, including certain urea components. These advancements are pivotal in ensuring safe and hygienic contact lens use for consumers.

Career Highlights

Priscilla has made her mark in the industry while working at Allergan, Inc., a prominent player in the field of eye care and therapeutic solutions. Her dedication to research and innovation has led to the successful application of her patent, further solidifying Allergan's reputation for excellence in ophthalmic products.

Collaborations

Throughout her career, Priscilla has collaborated with notable colleagues, including Joseph E. Vigh and Anthony J. Dziabo. These partnerships have been instrumental in driving innovative projects and expanding the scope of research within the company, enhancing the overall efficacy of their eye care offerings.

Conclusion

Priscilla Lo's work exemplifies the spirit of innovation within the ophthalmic sector. Her single, yet impactful patent reflects a commitment to improving eye care solutions, and her position at Allergan highlights her contributions to the development of effective and safe ophthalmic compositions. As she continues her journey in the field, her collaboration with esteemed coworkers only serves to bolster the potential for future innovations in eye health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…